May 9 (Reuters) - Valeant Pharmaceuticals (NYSE:VRX) Announces Expected
Timing Of Form 10 VRX.TO
* Expects to file its form 10-Q for quarter ended march 31,
2016 on or before June 10, 2016
* Expects quarterly filings for quarter ending June 30, 2016
and thereafter will be filed with SEC and Canadian regulators on
timely basis
* Valeant Pharmaceuticals announces expected timing of form
10-Q filing and reiterates 2016 first quarter guidance
Source text for Eikon: ID:nCNWFjJg5a
Further company coverage: VRX.TO
(Bengaluru Newsroom: +1-646-223-8780)